Free Trial
NASDAQ:GELS

Gelteq (GELS) Stock Price, News & Analysis

Gelteq logo
$1.92 0.00 (0.00%)
As of 02/21/2025 03:59 PM Eastern

About Gelteq Stock (NASDAQ:GELS)

Key Stats

Today's Range
$1.92
$2.10
50-Day Range
$1.92
$3.29
52-Week Range
$1.42
$5.50
Volume
8,605 shs
Average Volume
51,430 shs
Market Capitalization
$18.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Gelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.

Receive GELS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter.

GELS Stock News Headlines

A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. With the news cycle dominated by the tariffs… Elon’s DOGE… and the Russia peace talks… Hidden in America's forgotten towns, a groundbreaking energy discovery is taking shape. And it's happening right in our own backyard – in the heart of Appalachia.
See More Headlines

GELS Stock Analysis - Frequently Asked Questions

Gelteq's stock was trading at $2.32 at the beginning of 2025. Since then, GELS stock has decreased by 17.2% and is now trading at $1.92.
View the best growth stocks for 2025 here
.

Gelteq (GELS) raised $5 million in an IPO on Tuesday, October 29th 2024. The company issued 1,300,000 shares at a price of $4.00 per share. The Benchmark Company acted as the underwriter for the IPO.

Gelteq's lock-up period expires on Monday, April 28th. Gelteq had issued 1,300,000 shares in its public offering on October 29th. The total size of the offering was $5,200,000 based on an initial share price of $4.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Gelteq's top institutional shareholders include Citadel Advisors LLC (0.25%).

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
2/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GELS
Previous Symbol
NASDAQ:GELS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$18.12 million
Optionable
N/A
Beta
N/A
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GELS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners